Liminatus Pharma Inc (LIMN)

06:20 AM

Liminatus announces proposed merger with InnocsAI - The Pharma Letter

06:20 AM

May 23, 2026

Liminatus Pharma notifies NASDAQ of impending delisting; plans to appeal - MSN

May 23, 2026

May 23, 2026

LIMN Should I Buy - Intellectia AI

May 23, 2026

May 22, 2026

Liminatus Pharma (LIMN) Faces Delisting from Nasdaq - GuruFocus

May 22, 2026

May 22, 2026

Liminatus Pharma (LIMN) Faces Nasdaq Delisting Notice Amid Compl - GuruFocus

May 22, 2026

May 22, 2026

Liminatus Pharma (LIMN) Plunges 31% as Support Level Approaches – Key Levels to WatchExpert Breakout Alerts - Newser

May 22, 2026

May 22, 2026

Liminatus Pharma receives Nasdaq delisting notice - TipRanks

May 22, 2026

May 22, 2026

Number of shareholders of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView

May 22, 2026

May 22, 2026

LIMN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

May 22, 2026

May 22, 2026

Liminatus Pharma (LIMN) Stock: Surges Ahead of Nasdaq Delisting Deadline - MEXC

May 22, 2026

May 22, 2026

Liminatus Pharma (LIMN) Stock: Nasdaq Delisting Warning Sparks Volatile Trading Session - Blockonomi

May 22, 2026

May 22, 2026

Liminatus Pharma (LIMN) Stock Jumps 31% Despite Looming Nasdaq Delisting Threat - MoneyCheck

May 22, 2026

May 22, 2026

Liminatus Pharma faces Nasdaq delisting after compliance failure By Investing.com - Investing.com Canada

May 22, 2026

May 21, 2026

Liminatus Pharma to be delisted from Nasdaq for failing market value rules, plans to appeal. - Pluang

May 21, 2026

May 21, 2026

Liminatus Pharma Announces Nasdaq Delisting Notification - lincolnjournal.com

May 21, 2026

May 21, 2026

Liminatus Pharma faces Nasdaq delisting after compliance failure - Investing.com

May 21, 2026

May 21, 2026

Liminatus Pharma, Inc. Receives Nasdaq Delisting Notice Following Non-Compliance with Market Value Requirements - Quiver Quantitative

May 21, 2026

May 21, 2026

Liminatus Pharma faces Nasdaq delisting after market value shortfall - Stock Titan

May 21, 2026

May 21, 2026

Liminatus Pharma Announces Nasdaq Delisting Notification - GlobeNewswire Inc.

May 21, 2026

May 21, 2026

Here are the top movers in Thursday's session. - ChartMill

May 21, 2026

May 21, 2026

Liminatus Pharma shares jump 79% after merger deal with InnocsAI announced - Pluang

May 21, 2026

May 21, 2026

Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) Stock Quote - The Chronicle-Journal

May 21, 2026

May 21, 2026

Most active stocks in Thursday's session - ChartMill

May 21, 2026

May 21, 2026

LIMN Stock Surges 39% as Liminatus Pharma Gains Momentum - Meyka

May 21, 2026

May 21, 2026

Liminatus Pharma: Deal Represents Transaction Value of About $320M >LIMN - Moomoo

May 21, 2026

May 21, 2026

Trending Stocks Today | Liminatus Pharma Surges 62.75% - Moomoo

May 21, 2026

May 21, 2026

Liminatus Pharma to merge with InnocsAI, expanding oncology cell therapy pipeline with $320M deal - Pluang

May 21, 2026

May 21, 2026

LIMN Stock Rises in Pre-Market on Liminatus InnocsAI Deal News - Bez Kabli

May 21, 2026

May 21, 2026

What's going on in today's pre-market session - ChartMill

May 21, 2026

May 21, 2026

Struggling Liminatus pays $320M in stock for CAR-T biotech InnocsAI - Fierce Biotech

May 21, 2026

May 21, 2026

Cancer biotech Liminatus lines up $320M deal for new cell therapies - Stock Titan

May 21, 2026

May 21, 2026

Top Premarket Gainers - Moomoo

May 21, 2026

May 21, 2026

Trending Stocks Today | Triller Group Soars 60.16% Pre-Market - Moomoo

May 21, 2026

May 21, 2026

Liminatus Pharma Is Trending Overnight — Here's Why LIMN Stock Surged Over 79% In After-Hours Session - Benzinga

May 21, 2026

May 20, 2026

Liminatus Pharma Announces Merger Agreement with InnocsAI LLC to Expand CAR-T Therapy Technologies - Minichart

May 20, 2026

May 20, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

May 20, 2026

May 20, 2026

Liminatus Pharma to Acquire InnocsAI in Stock Deal, 1.6B Shares at $0.20 Plus CVRs - TradingView

May 20, 2026

May 20, 2026

Liminatus Pharma (LIMN) plans all-stock InnocsAI merger with CAR-T pipeline - Stock Titan

May 20, 2026

May 19, 2026

Liminatus Pharma, Inc. agreed to acquire InnocsAI LLC for approximately $320 million. - marketscreener.com

May 19, 2026

May 15, 2026

Liminatus Pharma 1Q 2026: Net loss $1.12M, Diluted EPS $(0.03) — 10-Q Summary - TradingView

May 15, 2026

May 15, 2026

Liminatus Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026

May 15, 2026

Liminatus Pharma (NASDAQ: LIMN) Q1 loss, going concern and Nasdaq listing risks - Stock Titan

May 15, 2026

May 13, 2026

TradingKey - TradingKey

May 13, 2026

May 11, 2026

Why Liminatus (LIMNW) is still under the radar (+33.11%) 2026-05-11Sector Leader - Newser

May 11, 2026

May 11, 2026

The key risks discussed in Liminatus Pharma (LIMN) earnings | LIMN QX Earnings: Liminatus Pharma Reports No Revenue, Pipeline FocusEarnings Revision Downgrade - Newser

May 11, 2026

May 11, 2026

LIMN QX Earnings: Liminatus Pharma Reports No Revenue, Pipeline FocusMacro Risk - newser.com

May 11, 2026

May 09, 2026

What Liminatus (LIMNW) disclosed about workforce costs | LIMNW: Liminatus Warrants Report No Earnings DataLiquidity Risk - Newser

May 09, 2026

May 01, 2026

Net current asset value per share of Liminatus Pharma, Inc. – NASDAQ:LIMN - TradingView

May 01, 2026

Apr 27, 2026

LIMNW Price History for Liminatus Pharma Warrants Stock - Barchart.com

Apr 27, 2026

Apr 26, 2026

Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN

Apr 26, 2026

Apr 24, 2026

Is Liminatus (LIMNW) stock trending down today | Liminatus Posts No Financials, Pipeline Drives Warrant MovesHigh Growth - newser.com

Apr 24, 2026